Efficacy of Epirubicin and Epirubicin Polybutylcyanoacrylate Nanoparticles Against Transplanted Liver Tumor in Rrats

LEI Lei,ZHANG Xu,ZHANG Yang-de

DOI: https://doi.org/10.3969/j.issn.1004-7239.2006.04.006

2006-01-01

Abstract:Objective To evaluate the therapeutic effects of Epirubicin Polybutylcyanoacrylate nanoparticles against transplanted malignant liver tumor in rats via vena caudalis.Methods Thirty-six rat models of transplanted liver were established.After two weeks,12 rat models were selected in them randomly and were carried out through a midline abdominal incision.The diameter of tumor was measured.The other rat models were medially divided into two groups at random.1)Free Epirubicin treated(EPI) group.2)Epirubicin Polybutylcyanoacrylate nanoparticles(EPI-PBCA-NP) treated group.Each group was administered via vena caudalis by turns.The survival days of the animals after administration were recorded.After one week,abdominal exposure was carried out through a midline abdominal incision again.Volume of tumor,tumor growth rate,degree of tumor necrosis and increasing longer survival were noted and investigated.Results After therapy,statistic difference was found in volume of tumors of each group(P<0.01).Conspicuous statistic difference was found in tumor growth rate between EPI group and EPI-PBCA-NP group(P<0.01).EPI-PBCA-NP group was found remarkable necrosis extensively comparing with EPI groups(P<0.01).The tumor was replace of fibril tissue and non-structure tissue.Comparing with EPI group,prolonged survival rate of EPI-PBCA-NP group was 80.95%.Survival time of EPI-PBCA-NP group was prolonged remarkably comparing with EPI group(P<0.01).Conclusion Comparing with EPI group,the tumor growth rate was decreased significantly and prolonged survival rate was increased significantly in EPI-PBCA-NP group.